ANZUP’s mission is to improve the lives of people affected by bladder, kidney, testicular, penile and prostate cancers through practice-changing multidisciplinary collaborative clinical trials.
We do this by:
- bringing together clinicians, scientists and consumers to identify critical areas of unmet need that can be addressed through research in Australia and New Zealand
- providing a collaborative forum to generate research ideas and concepts that address critical clinical questions
- providing services and resources to support and fund research of the highest quality
- promoting access to clinical trials for all people affected by urogenital cancers in Australia and New Zealand
- mentoring and building the skills of future research leaders
- securing government, industry and philanthropic funding to facilitate our independent research agenda
- promoting our research goals and progress to improve clinical practice and change lives.
ANZUP strategic priorities: our goals 2021-2024:
Goal one: Conduct high-quality, multidisciplinary, practice-changing clinical trials in urogenital* cancers
Goal two: Maintain a portfolio of trials relevant to and accessible by all people with urogenital cancers in Australia and New Zealand
Goal three: Strengthen ANZUP’s capacity for practice-changing clinical trials
Goal four: Forward plan to maintain a vibrant and active urogenital cancer trials community
Goal five: Provide leadership in collaborative cancer clinical trials